Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€156.00

€156.00

0.680%
1.0
0.680%
€241.54
 
12.06.24 / Tradegate WKN: A1437N / Symbol: BGNE / Name: BeiGene / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

BeiGene Ltd ADR Stock

The BeiGene Ltd ADR stock is trending slightly upwards today, with an increase of €1.00 (0.680%) compared to yesterday's price.
With 9 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 241 € shows a very positive potential of 54.49% compared to the current price of 156.0 € for BeiGene Ltd ADR.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for BeiGene Ltd ADR stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of BeiGene Ltd ADR in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of BeiGene Ltd ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
BeiGene Ltd ADR 0.680% 6.849% 4.698% -19.171% -5.455% -45.455% -
Ardelyx Inc. -2.120% -0.836% -17.621% 59.355% 2.561% -3.610% -
Evolus Inc -2.750% -3.636% -8.621% 45.205% 17.127% 4.950% -
Salarius Pharmaceuticals Inc. - 9.942% -9.179% -75.263% -32.252% -98.425% -99.995%

Comments

Prediction Buy
Perf. (%) -0.64%
Target price 235.585
Change
Ends at 09.05.25

BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $236.00 to $254.00. They now have a "buy" rating on the stock.
Ratings data for BGNE provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 10.95%
Target price 220.613
Change
Ends at 24.04.25

BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at TD Cowen from $235.00 to $236.00. They now have a "buy" rating on the stock.
Ratings data for BGNE provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.65%
Target price 171.399
Change
Ends at 20.03.25

BeiGene, Ltd. (NASDAQ: BGNE) had its price target raised by analysts at JPMorgan Chase & Co. from $184.00 to $186.00. They now have an "overweight" rating on the stock.
Ratings data for BGNE provided by MarketBeat
Show more